By Elaine Chen This image provided by Novo Nordisk in January 2023, shows packaging for the company’s Wegovy drug.NOVO NORDISK VIA AP PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss. The company in August had...
